Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Charles Spicer
AddedMar 31, 2024
UpdatedMay 31, 2026
Charles Spicer

Charles Spicer

Board Member, Creo Medical

CrunchbaseLinkedIn

Charles Spicer's Career

Creo Medical
Creo Medical

Chepstow, Gwent, GB

Board Member· Board
Netscientific
Netscientific

Beaconsfield, Buckinghamshire, GB

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Charles Spicer's Career

Creo Medical
Creo Medical
Public$90.3M772003Chepstow, Gwent, GB
Board Member· Board

Leadership at Creo Medical

Chris HancockChris HancockCo-Founder
Steve MorrisSteve MorrisCo-Founder
Dr. Craig GullifordDr. Craig GullifordCEO

Similar to Creo Medical

CremedicalCremedicalKingston, RI, USMedical Devicesest. 2011CremedicalKingston, RI, US · est. 2011

CREmedical: Pioneering neurology equipment for brain study and mental illness treatment since 2011.

Pre-Seed · $1.4M2
MedicreationsMedicreationsLas Vegas, NV, USMedical Devicesest. 2016MedicreationsLas Vegas, NV, US · est. 2016

Medicreations: A Las Vegas-based medical device manufacturer, serving practitioners since 2016.

Seed · $2.5M24
Proa MedicalProa MedicalRedondo Beach, CA, USMedical Devicesest. 2010Proa MedicalRedondo Beach, CA, US · est. 2010

Proa Medical: High-throughput developer and distributor of innovative medical devices.

Pre-Seed · $2.8M2
Concept MedicalConcept MedicalTampa, FL, USMedical Devicesest. 2008Concept MedicalTampa, FL, US · est. 2008

Concept Medical: Innovating treatments for coronary and peripheral artery diseases with advanced medical devices.

Series D · $60M234
Netscientific
Netscientific
Investment FirmInvestment Firm262012Beaconsfield, Buckinghamshire, GB
Board Member· Board

Leadership at Netscientific

Ilian IlievIlian IlievCEO
Farad AzimaFarad AzimaFounder
Stephen SmithStephen SmithBoard Member
Jonathan Mark RobinsonJonathan Mark RobinsonBoard Member
Stephen CroweStephen CroweBoard Member

Similar to Netscientific

Digital ScienceDigital ScienceLondon, Greater London, GBest. 2010Digital ScienceLondon, Greater London, GB · est. 2010

UK tech firm investing in startups, serving scientific research communities.

Investment Firm250
ScienceScienceSanta Monica, CA, USest. 2011ScienceSanta Monica, CA, US · est. 2011

Science partners, developing and funding disruptive tech-based companies.

Investment Firm · $72.3M236
Endpoint VenturesEndpoint VenturesSan Francisco, CA, USest. 2015Endpoint VenturesSan Francisco, CA, US · est. 2015

Early-stage investment firm specializing in healthcare, life sciences, diagnostics, and therapeutics.

Investment Firm2
Scientia VenturesScientia Venturesest. 2006Scientia Venturesest. 2006

Scientia Ventures: Investing in early to mid-stage tech firms innovating in life sciences and digital medicine.

Investment Firm9

Charles Spicer's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailJaeHong ChoiJaeHong ChoiBoard Member · KakaoMason YeoMason YeoBoard Member · Kakao

People Similar to Charles Spicer

Dennis YangDennis YangBoard Member · Modal.ioSebastian SpiesSebastian SpiesCo-Founder · Datapath.ioPhilip StaehelinPhilip StaehelinBoard Member · StartupYardDavid BrunelDavid BrunelBoard Member · BiodesixChristian JorgChristian JorgCo-Founder & CEO · OpentopicDavid WibleDavid WibleCo-Founder · Work.software